Zhan et al. also reported that in a mouse model of angiotensin-induced atrial fibrillation for 14 days, simultaneous administration of RKT prevented atrial fibrosis and reduced inflammatory cytokine levels by enhancing the growth hormone secretagogue receptor-Sirt1 pathway, independent of ghrelin [24]. The gene discussed is GHRL; the disease is atrial fibrillation.